{"id":106680,"date":"2025-10-09T17:12:35","date_gmt":"2025-10-09T15:12:35","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/"},"modified":"2025-10-13T14:57:19","modified_gmt":"2025-10-13T12:57:19","slug":"cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/","title":{"rendered":"CDTI Innovation leads a \u20ac10 million investment in Ona Therapeutics together with five co-investors"},"content":{"rendered":"<p><strong>The biotechnology company <a href=\"https:\/\/www.pcb.ub.edu\/en\/empresa\/ona-therapeutics\/\" target=\"_blank\" rel=\"noopener\">Ona Therapeutics<\/a>, located in the Barcelona Science Park, has received a \u20ac10 million investment, led by SICC Innvierte of CDTI Innovation, to advance the development of new therapies for advanced cancer using ADCs (antibody-drug conjugates). The round also included participation from co-investors Asabys Partners, Ysios Capital Partners, Alta Life Science, the European Venture Capital Fund (FCRE), and Fund+. The funds will be used to develop ADCs and antibody-based therapies, with the goal of providing new treatment options for patients with advanced cancer, who currently have no effective alternatives.<\/strong><\/p>\n<p>Ona Therapeutics is a pioneer in the development of first-generation antibody-drug conjugates (ADCs) that leverage the molecular foundations of advanced cancer. The company collaborates with academic and medical experts to design therapies that address the complexity of the disease and meet unmet clinical needs. Patients with advanced cancer have often undergone multiple lines of treatment, and their disease progression presents significant challenges due to the limited understanding of how cancer evolves throughout these therapies, making it difficult to identify new therapeutic targets.<\/p>\n<p>This spin-off from the Institute for Research in Biomedicine (<a href=\"https:\/\/www.pcb.ub.edu\/en\/empresa\/institut-de-recerca-biomedica-irb-barcelona\/\" target=\"_blank\" rel=\"noopener\">IRB Barcelona<\/a>) applies an innovative approach by incorporating samples from refractory patients, allowing the analysis of how standard treatments transform cancer at the molecular level. Thanks to this knowledge, Ona Therapeutics can identify new therapeutic targets beyond traditional tumour antigens and define patient populations in which these therapies are likely to be most effective.<\/p>\n<p>With this investment, Ona Therapeutics strengthens its strategy for developing ADCs and antibody-based therapies, consolidating its position as a leading company in innovation against advanced cancer.<\/p>\n<p><strong>\u00bb Link to the news:<\/strong> <a href=\"https:\/\/www.cdti.es\/en\/node\/24285\" target=\"_blank\" rel=\"noopener\">CDTI webstite [+]<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The biotechnology company Ona Therapeutics, located in the Barcelona Science Park, has received a \u20ac10 million investment, led by SICC Innvierte of CDTI Innovation, to advance the development of new&#8230;<\/p>\n","protected":false},"author":14,"featured_media":106674,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[35],"tags":[268],"class_list":["post-106680","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-ona-therapeutics-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CDTI Innovation leads a \u20ac10 million investment in Ona Therapeutics together with five co-investors - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"description\" content=\"The round included participation from Asabys Partners, Ysios Capital Partners, Alta Life Science, FCRE, and Fund+.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CDTI Innovation leads a \u20ac10 million investment in Ona Therapeutics together with five co-investors - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"The round included participation from Asabys Partners, Ysios Capital Partners, Alta Life Science, FCRE, and Fund+.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-09T15:12:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T12:57:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/10\/Adobe-Express-file-57.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Paula Ca\u00f1al\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paula Ca\u00f1al\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\\\/\"},\"author\":{\"name\":\"Paula Ca\u00f1al\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"headline\":\"CDTI Innovation leads a \u20ac10 million investment in Ona Therapeutics together with five co-investors\",\"datePublished\":\"2025-10-09T15:12:35+00:00\",\"dateModified\":\"2025-10-13T12:57:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\\\/\"},\"wordCount\":280,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Adobe-Express-file-57.jpg\",\"keywords\":[\"Ona Therapeutics\"],\"articleSection\":[\"COMPANIES\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\\\/\",\"name\":\"CDTI Innovation leads a \u20ac10 million investment in Ona Therapeutics together with five co-investors - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Adobe-Express-file-57.jpg\",\"datePublished\":\"2025-10-09T15:12:35+00:00\",\"dateModified\":\"2025-10-13T12:57:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"description\":\"The round included participation from Asabys Partners, Ysios Capital Partners, Alta Life Science, FCRE, and Fund+.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Adobe-Express-file-57.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Adobe-Express-file-57.jpg\",\"width\":900,\"height\":330},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CDTI Innovation leads a \u20ac10 million investment in Ona Therapeutics together with five co-investors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\",\"name\":\"Paula Ca\u00f1al\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"caption\":\"Paula Ca\u00f1al\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/author\\\/paula\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CDTI Innovation leads a \u20ac10 million investment in Ona Therapeutics together with five co-investors - Parc Cient\u00edfic de Barcelona","description":"The round included participation from Asabys Partners, Ysios Capital Partners, Alta Life Science, FCRE, and Fund+.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/","og_locale":"en_US","og_type":"article","og_title":"CDTI Innovation leads a \u20ac10 million investment in Ona Therapeutics together with five co-investors - Parc Cient\u00edfic de Barcelona","og_description":"The round included participation from Asabys Partners, Ysios Capital Partners, Alta Life Science, FCRE, and Fund+.","og_url":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2025-10-09T15:12:35+00:00","article_modified_time":"2025-10-13T12:57:19+00:00","og_image":[{"width":900,"height":330,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/10\/Adobe-Express-file-57.jpg","type":"image\/jpeg"}],"author":"Paula Ca\u00f1al","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Paula Ca\u00f1al","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/"},"author":{"name":"Paula Ca\u00f1al","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"headline":"CDTI Innovation leads a \u20ac10 million investment in Ona Therapeutics together with five co-investors","datePublished":"2025-10-09T15:12:35+00:00","dateModified":"2025-10-13T12:57:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/"},"wordCount":280,"image":{"@id":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/10\/Adobe-Express-file-57.jpg","keywords":["Ona Therapeutics"],"articleSection":["COMPANIES"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/","url":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/","name":"CDTI Innovation leads a \u20ac10 million investment in Ona Therapeutics together with five co-investors - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/10\/Adobe-Express-file-57.jpg","datePublished":"2025-10-09T15:12:35+00:00","dateModified":"2025-10-13T12:57:19+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"description":"The round included participation from Asabys Partners, Ysios Capital Partners, Alta Life Science, FCRE, and Fund+.","breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/10\/Adobe-Express-file-57.jpg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2025\/10\/Adobe-Express-file-57.jpg","width":900,"height":330},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/en\/cdti-innovation-leads-a-e10-million-investment-in-ona-therapeutics-together-with-five-co-investors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/en\/"},{"@type":"ListItem","position":2,"name":"CDTI Innovation leads a \u20ac10 million investment in Ona Therapeutics together with five co-investors"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a","name":"Paula Ca\u00f1al","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","caption":"Paula Ca\u00f1al"},"url":"https:\/\/www.pcb.ub.edu\/en\/author\/paula\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/106680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/comments?post=106680"}],"version-history":[{"count":1,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/106680\/revisions"}],"predecessor-version":[{"id":106740,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/106680\/revisions\/106740"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/media\/106674"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/media?parent=106680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/categories?post=106680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/tags?post=106680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}